Vitamin A and infant mortality: beyond intention-to-treat in a randomized trial.
This paper investigates the effect of one dose of vitamin A on subsequent 4 month mortality in children under 6 months of age in a randomized, double-blind placebo-controlled community trial in Nepal. An earlier published intention-to-treat analysis showed no benefit, but ignored the information on actual receipt of treatment. Structural failure time models (Robins and Tsiatis, '91) use randomization based inference and incorporate compliance information which is possibly selective. The data presented here offer some new challenges for this approach: ward-based randomization induces correlation between survival outcomes; and the actual receipt of vitamin A dose is not always recorded. To tackle the problem of the clustered survival data we consider a robust version of the structural parameter vector estimator. A sensitivity analysis captures boundaries for the estimated structural parameters reflecting a range of potential values of children whose true receipt of treatment is unknown. The analysis suggests that the effect of vitamin A was beneficial in the beginning of the trial but towards the end of the trial there was a reversal of this effect.
Korhonen
P
P
National Public Health Institute, Helsinki, Finland.
Loeys
T
T
Goetghebeur
E
E
Palmgren
J
J
D004311:Double-Blind Method; D006801:Humans; D007223:Infant; D007226:Infant Mortality; D007231:Infant, Newborn; D009390:Nepal; D010349:Patient Compliance; D010919:Placebos; D014801:Vitamin A / Q000008:administration & dosage*
D010919:Placebos; D014801:Vitamin A